3
Letter to the Editor Attentional set-shifting decits correlate with the severity of freezing of gait in Parkinsons disease Keywords: Parkinsons disease Freezing of gait Trail making test Attentional set-shifting Freezing of gait (FOG) is a poorly understood symptom of Par- kinsons disease (PD) during which a patient suffers an abrupt cessation of walking [1]. Whilst little consensus exists regarding the mechanisms underlying FOG [2], there is considerable evidence that additional cognitive demand whilst walking represents a signicant trigger in the pathophysiology of FOG [2]. In addition, the severity of self-reported FOG has been correlated with a selec- tive decit in attentional set-shifting [3]. Taken together, these ndings suggest a degree of commonality between corticostriatal networks serving attention and the pathophysiology of FOG. However, no study has directly linked clinical measures of FOG severity during walking with diminished executive function, in particular the ability to rapidly switch between tasks. In this study we hypothesized that impaired behavioral performance on cogni- tive testing should correlate with objective measures of actual freezing events whilst walking. Twenty-six PD patients with self-reported FOG were recruited from the Parkinsons Disease Research Clinic at the Brain and Mind Research Institute (Table 1). The study was approved by The Univer- sity of Sydney Human Research and Ethics Committee and written informed consent was obtained. Patients satised UKPDS Brain Bank criteria and were deemed unlikely to have dementia or major depression according to DSM-IV criteria. They were also assessed on the new Movement Disorders Society Unied Parkinsons Disease Rating Scale (UPDRS-III). Patients were screened for the study by answering positively to item three of the Freezing of Gait Question- naire (FOG-Q3 Do you feel that your feet get glued to the oor while walking, making a turn or when trying to initiate walking (freezing)?) [4]. Patients were assessed in their practically-dened Offstate following overnight withdrawal of dopaminergic therapy. Patients performed a series of standardized timed up-and-go (TUG) tasks [5], which started in the sitting position from which patients walked 5 m at their preferred pace toward a 0.6 m 2 target box marked on the oor, where participants made a 180 or 540 turn (counterbalanced left and right) on two occasions before returning to sit in the chair. No dual-tasking was performed. Similar to a previous study [5], freezing episodes were dened as the paroxysmal absence of forward progression of the feet despite the intention to walk. TUG trials were video-recorded for post hoc analysis by two experienced clinical raters (intra-class correlation coefcient [ICC] for number of FOG ¼ 0.82; percent time frozen ICC ¼ 0.99) [5]. Where agreement could not be reached the data were not included for further analysis (n ¼ 15/336 episodes). Following rating, we calculated the total number of FOG events as well as the percent time frozen(time spent frozen as a proportion of total time spent walking). Although 5 of the 26 patients (19%) did not suffer from a freezing episode during the TUG assessment, they were included in the nal analysis so as to appropriately model the spectrum of freezing behavior. Patients performed the Trail Making Test part A (TMT A drawing a line linking consecutive numbers from 1 to 25) and part B (TMT B drawing a line connecting alternating numbers and letters in sequence; e.g. 1 A 2 B .). As has been described previously, the difference in time to completion between TMT B and TMT A (TMT BA ) measured the patients ability to rapidly set-shift[3]. Bivariate Spearmans rankorder correlations were calculated between TMT BA and percent time frozen and the number of freezing episodes using the SPSS software package (Version 19.0). All tests were two-tailed with an alpha of 0.05. The TUG tasks were successful in eliciting FOG in 21 of the 26 patients (81%) with a total of 321events, averaging 12.3 (SD 11.2) per patient (median 11; range 078). The mean percent time frozen was 30.9% (SD 30.1; median 29.0; range 0.078.0). TMT BA was signicantly correlated with both percent time frozen (Fig. 1A: Spearmans rho ¼ 0.530; p ¼ 0.005) and the number of freezing episodes (Fig. 1B: rho ¼ 0.420; p ¼ 0.033). Both of the correlations remained signicant after performing a partial correla- tion with the total UPDRS score (percent time frozen: rho ¼ 0.540; p ¼ 0.004; number of episodes: rho ¼ 0.463; p ¼ 0.017). In addition, motor severity (UPDRS-III) was not signicantly correlated with TMT BA (rho ¼ 0.261; p ¼ 0.190) or either measure of FOG (percent: rho ¼ 0.038; p ¼ 0.841; number: rho ¼0.090; p ¼ 0.624). While a relationship between FOG and cognitive dysfunction has long been recognized in PD patients [2,3], this is the rst study to show a signicant correlation between impaired performance on Contents lists available at SciVerse ScienceDirect Parkinsonism and Related Disorders journal homepage: www.elsevier.com/locate/parkreldis Parkinsonism and Related Disorders 19 (2013) 388390 1353-8020/$ see front matter Crown Copyright Ó 2012 Published by Elsevier Ltd. All rights reserved. http://dx.doi.org/10.1016/j.parkreldis.2012.07.015

Attentional set-shifting deficits correlate with the severity of freezing of gait in Parkinson's disease

  • Upload
    tr

  • View
    212

  • Download
    0

Embed Size (px)

Citation preview

at SciVerse ScienceDirect

Parkinsonism and Related Disorders 19 (2013) 388–390

Contents lists available

Parkinsonism and Related Disorders

journal homepage: www.elsevier .com/locate/parkreldis

Letter to the Editor

Attentional set-shifting deficits correlate with the severity of freezing of gaitin Parkinson’s disease

Keywords:Parkinson’s diseaseFreezing of gaitTrail making testAttentional set-shifting

1353-8020/$ – see front matter Crown Copyright � 2http://dx.doi.org/10.1016/j.parkreldis.2012.07.015

Freezing of gait (FOG) is a poorly understood symptom of Par-kinson’s disease (PD) during which a patient suffers an abruptcessation of walking [1]. Whilst little consensus exists regardingthe mechanisms underlying FOG [2], there is considerable evidencethat additional cognitive demand whilst walking representsa significant trigger in the pathophysiology of FOG [2]. In addition,the severity of self-reported FOG has been correlated with a selec-tive deficit in attentional set-shifting [3]. Taken together, thesefindings suggest a degree of commonality between corticostriatalnetworks serving attention and the pathophysiology of FOG.However, no study has directly linked clinical measures of FOGseverity during walking with diminished executive function, inparticular the ability to rapidly switch between tasks. In this studywe hypothesized that impaired behavioral performance on cogni-tive testing should correlate with objective measures of actualfreezing events whilst walking.

Twenty-six PD patients with self-reported FOG were recruitedfrom the Parkinson’s Disease Research Clinic at the Brain and MindResearch Institute (Table 1). The study was approved by The Univer-sity of Sydney Human Research and Ethics Committee and writteninformed consent was obtained. Patients satisfied UKPDS BrainBank criteria and were deemed unlikely to have dementia or majordepression according to DSM-IV criteria. They were also assessed onthe new Movement Disorders Society Unified Parkinson’s DiseaseRating Scale (UPDRS-III). Patients were screened for the study byanswering positively to item three of the Freezing of Gait Question-naire (FOG-Q3 – “Do you feel that your feet get glued to the floor whilewalking, making a turn or when trying to initiate walking (freezing)?”)[4]. Patients were assessed in their practically-defined ‘Off’ statefollowing overnight withdrawal of dopaminergic therapy.

Patients performed a series of standardized timed up-and-go(TUG) tasks [5], which started in the sitting position from whichpatients walked 5 m at their preferred pace toward a 0.6 m2 targetbox marked on the floor, where participants made a 180� or 540�

turn (counterbalanced left and right) on two occasions beforereturning to sit in the chair. No dual-tasking was performed.

Similar to a previous study [5], freezing episodes were definedas the paroxysmal absence of forward progression of the feet

012 Published by Elsevier Ltd. All

despite the intention to walk. TUG trials were video-recorded forpost hoc analysis by two experienced clinical raters (intra-classcorrelation coefficient [ICC] for number of FOG ¼ 0.82; percenttime frozen ICC ¼ 0.99) [5]. Where agreement could not be reachedthe data were not included for further analysis (n ¼ 15/336episodes). Following rating, we calculated the total number ofFOG events as well as the ‘percent time frozen’ (time spent frozenas a proportion of total time spent walking). Although 5 of the 26patients (19%) did not suffer from a freezing episode during theTUG assessment, they were included in the final analysis so as toappropriately model the spectrum of freezing behavior.

Patients performed the Trail Making Test part A (TMTA –

drawing a line linking consecutive numbers from 1 to 25) andpart B (TMTB – drawing a line connecting alternating numbersand letters in sequence; e.g. 1 – A – 2 – B – .). As has beendescribed previously, the difference in time to completion betweenTMTB and TMTA (TMTB–A) measured the patient’s ability to rapidly‘set-shift’ [3].

Bivariate Spearman’s rank–order correlations were calculatedbetween TMTB–A and percent time frozen and the number offreezing episodes using the SPSS software package (Version 19.0).All tests were two-tailed with an alpha of 0.05.

The TUG tasks were successful in eliciting FOG in 21 of the 26patients (81%) with a total of 321events, averaging 12.3 (SD 11.2)per patient (median 11; range 0–78). The mean percent time frozenwas 30.9% (SD 30.1; median 29.0; range 0.0–78.0).

TMTB–A was significantly correlated with both percent timefrozen (Fig.1A: Spearman’s rho¼ 0.530; p¼ 0.005) and the numberof freezing episodes (Fig. 1B: rho ¼ 0.420; p ¼ 0.033). Both of thecorrelations remained significant after performing a partial correla-tion with the total UPDRS score (percent time frozen: rho ¼ 0.540;p¼ 0.004; number of episodes: rho¼ 0.463; p¼ 0.017). In addition,motor severity (UPDRS-III) was not significantly correlated withTMTB–A (rho ¼ 0.261; p ¼ 0.190) or either measure of FOG (percent:rho ¼ 0.038; p ¼ 0.841; number: rho ¼ �0.090; p ¼ 0.624).

While a relationship between FOG and cognitive dysfunctionhas long been recognized in PD patients [2,3], this is the first studyto show a significant correlation between impaired performance on

rights reserved.

Table 1Demographic, neurological, cognitive and freezing characteristics of the sample.UPDRS III ¼ Unified Parkinson’s disease rating Scale motor Subsection;FOG-Q ¼ freezing of gait questionnaire.

Range Mean SD

N ¼ 26Age, years 57–85 68.3 7.6Hoehn and Yahr, stage 2–4 2.6 0.5UPDRS III 13–65 38.0 12.0Dopamine dose equivalence, mg/day 100–2400 1002.5 639.3Freezing questionnairesFOG-Q total 9–22 14.3 3.9

Neuropsychological assessmentMini-mental state examination 24–30 28.2 1.7Trail making Test B–A, (s) 17–206 83.3 45.9

Clinical assessmentNumber of FOG episodes 0–38 12.3 11.2Percent time frozen 0.0–78.0 30.9 30.1

Letter to the Editor / Parkinsonism and Related Disorders 19 (2013) 388–390 389

a specific neuropsychological test of set-shifting and objective clin-ical measures of FOG severity. These results extend previous worklinking attentional set-shifting impairment with self-reportedFOG symptoms [3].

We did not find any evidence for a significant correlationbetween attentional-set shifting and the severity of Parkinsoniansymptoms, suggesting that the attentional set-shifting impair-ments seen in FOG were not simply due to worse PD severity. Inaddition, the results of the study could not confirm any correlationbetween the severity of self-reported symptoms and the amount ofactual FOG observed in the ‘Off’ state. This finding is consistent witha recent study that demonstrated that ratings on such self-reportquestionnaires may not correlate with the actual severity offreezing during clinical assessment [5]. Previously, ratings on theFOG-Q have been correlated with performance on the TMTB–A [3],

Fig. 1. Trail making test performance versus FOG Severity. Scatterplot demonstratingthe correlation between the set-shifting component of the Trail making test (TMTB–A)and: a) The percent time frozen on the timed up-and-go tasks (Spearman’srho ¼ 0.520, p ¼ 0.005); and b) The number of freezing episodes on the timed up-and-go tasks (rho ¼ 0.420, p ¼ 0.033).

a finding that was not confirmed here. However, this earlier studywas conducted in a larger group of patients containing bothfreezers and non-freezers, suggesting that TMTB–A impairmentmay exist along a spectrum in PD.

The correlation between impaired set-shifting and FOG severityobserved in this study supports the hypothesis that an inability toshift between competing attentional demands may form part ofthe pathophysiological mechanisms underlying FOG [2]. A moreprofound understanding of these processes may have significantimplications for future clinical management. For instance, whilstcurrent therapies offer only limited symptom amelioration, it ispossible that targeted cognitive training therapies may prove bene-ficialwithout adding to analreadycomplicatedmedication regimen.

JM Shine –Conception, organization and execution of the researchproject; execution and reviewof the statistical analysis;writingof thefirst draft and reviewof themanuscript. STMoore –Conception of theresearch project; execution and review of the statistical analysis;review of the manuscript. NC Palavra – Execution of the researchproject; review of the statistical analysis; review of the manuscript.V Dilda – Execution of the research project; review of the statisticalanalysis; review of the manuscript. TR Morris – Execution of theresearch project; review of the statistical analysis; review of themanuscript. SL Naismith – Conception and organization of theresearch project; design and review of the statistical analysis; reviewof the manuscript. SJG Lewis – Conception of the research project;designand reviewof the statistical analysis; reviewof themanuscript.

Financial disclosure

JM Shine – supported by an Australian Rotary Health Scholar-ship. ST Moore – supported by the National Space BiomedicalResearch Institute and NASA grant NNX09AL14G. NC Palavra – nofinancial support. V Dilda – no financial support. TR Morris – nofinancial support. SL Naismith – supported by an NHMRC CareerDevelopment Award No. 1008117. SJG Lewis – supported by anNHMRC Practitioner Fellowship No. 1003007 and a University ofSydney Rolf Edgar Lake Postdoctoral Fellowship.

Acknowledgments

A number of the patients from this study were also included ina recent publication in Parkinsonism and Related Disorders [5].

References

[1] Giladi N, Kao R, Fahn S. Freezing phenomenon in patients with parkinsoniansyndromes. Mov Disord 1997;12:302–5.

[2] Shine JM,Naismith SL, Lewis SJG. Thepathophysiologicalmechanismsunderlyingfreezing of gait in Parkinson’s disease. J Clin Neurosci 2011;18:1154–7.

[3] Naismith SL, Shine JM, Lewis SJ. The specific contributions of set-shifting tofreezing of gait in Parkinson’s disease. Mov Disord 2010;25:1000–4.

[4] Giladi N, Shabtai H, Simon ES, Biran S, Tal J, Korczyn AD. Construction offreezing of gait questionnaire for patients with Parkinsonism. ParkinsonismRelat Disord 2000;6:165–70.

[5] Shine JM, Moore ST, Bolitho SJ, Morris TR, Dilda V, Naismith SL, et al. Assessingthe utility of freezing of gait questionnaires in Parkinson’s disease. Parkin-sonism Relat Disord 2011;18:25–9.

J.M. Shine, S.L. Naismith, N.C. Palavra, S.J.G. Lewis*Parkinson’s Disease Clinic, Brain and Mind Research Institute,

The University of Sydney, NSW, Australia

S.T. MooreHuman Aerospace Laboratory, Department of Neurology,

Mount Sinai School of Medicine, New York NY 10029, USA

Letter to the Editor / Parkinsonism and Related Disorders 19 (2013) 388–390390

Robert and John M. Bendheim Parkinson and Movement DisordersCenter, Department of Neurology, Mount Sinai School of Medicine,

New York NY 10029, USA

V. Dilda, T.R. MorrisHuman Aerospace Laboratory, Department of Neurology,

Mount Sinai School of Medicine, New York NY 10029, USA

* Corresponding author. Parkinson’s Disease Research Clinic, Brain& Mind Research Institute, University of Sydney, 94 Mallett Street,Camperdown, Sydney, NSW 2050, Australia. Tel.: þ61 2 9515 7565.

E-mail address: [email protected] (S.J.G. Lewis)

16 March 2012